GCOW Among Dividend Stocks ETFs
End-of-day Nov 17, 2026 · 324 Dividend stocks ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −0.7% | +1.3% | 0.0% | +17.6% | +20.3% | +68.3% | +94.4% | +194.6% |
| Peer average | −0.8% | −2.0% | −1.6% | −4.2% | +7.7% | +9.9% | +52.6% | +46.0% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | — |
$26 of every $1,000 in GCOW is Accenture
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ACNAccenture | Technology | 2.60% | $260.10 | 391K | $96.8M |
| 2 | MDTMedtronic | Healthcare | 2.36% | $235.78 | 853K | $87.7M |
| 3 | ULVR.LUnilever | Consumer Defensive | 2.22% | $222.11 | 1.2M | $82.6M |
| 4 | CVXChevron | Energy | 2.17% | $216.98 | 372K | $80.7M |
| 5 | PFEPfizer | Healthcare | 2.07% | $207.44 | 2.7M | $77.2M |
| 6 | PMPhilip Morris International | Consumer Defensive | 2.06% | $205.81 | 391K | $76.6M |
| 7 | BMYBristol-Myers Squibb | Healthcare | 2.06% | $205.67 | 1.2M | $76.5M |
| 8 | MOAltria Group | Consumer Defensive | 2.05% | $204.57 | 965K | $76.1M |
| 9 | NOVN.SWNovartis AG | Healthcare | 2.04% | $203.87 | 469K | $75.9M |
| 10 | NESN.SWNestle | Consumer Defensive | 2.03% | $202.86 | 720K | $75.5M |
| 11 | SAN.PASanofi | Healthcare | 2.02% | $202.05 | 774K | $75.2M |
| 12 | CMCSAComcast | Communication Services | 2.01% | $201.16 | 2.9M | $74.8M |
| 13 | BATS.LBritish American Tobacco | Consumer Defensive | 1.97% | $197.10 | 1.2M | $73.3M |
| 14 | CNQ.TOCanadian NAT RES | Energy | 1.97% | $197.02 | 1.5M | $73.3M |
| 15 | ENI.MIEni SpA | Energy | 1.96% | $195.70 | 2.6M | $72.8M |
of the $873B in 406 Dividend stocks ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ACN | Accenture | 2.60% |
| 2 | MDT | Medtronic | 2.36% |
| 3 | ULVR.L | Unilever | 2.22% |
| 4 | CVX | Chevron | 2.17% |
| 5 | PFE | Pfizer | 2.07% |
| 6 | PM | Philip Morris International | 2.06% |
| 7 | BMY | Bristol-Myers Squibb | 2.06% |
| 8 | MO | Altria Group | 2.05% |
| 9 | NOVN.SW | Novartis AG | 2.04% |
| 10 | NESN.SW | Nestle | 2.03% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 3, 2026 | Sep 8, 2026 | $0.43 |
| Jun 4, 2026 | Jun 8, 2026 | $0.42 |
| Mar 5, 2026 | Mar 9, 2026 | $0.42 |
| Dec 30, 2025 | Jan 5, 2026 | $1.01 |
| Sep 4, 2025 | Sep 10, 2025 | $0.28 |
| Jun 5, 2025 | Jun 11, 2025 | $0.32 |
| Mar 6, 2025 | Mar 12, 2025 | $0.0641 |
| Dec 27, 2024 | Jan 2, 2025 | $0.36 |
| Sep 26, 2024 | Oct 2, 2024 | $0.32 |
| Jun 27, 2024 | Jul 3, 2024 | $0.72 |
| Mar 21, 2024 | Mar 27, 2024 | $0.35 |
| Dec 27, 2023 | Jan 3, 2024 | $0.28 |